Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.
PR Newswire, 810 Seventh Avenue, New York, NY 10019 - May 1997.
Viatical funding companies raise money from investors to pay the terminally ill for their policies. The investor is named as an irrevocable beneficiary on the policy.
A law which became effective in 1997 grants exemption from federal income taxes for people with a life expectancy of 2 years or less who sell their policies to a viatical funding company. An investor who puts up money to purchase such a policy may receive a 28% return on his money. The return is guaranteed by the insurance company which issued the seller's policy. Bellevue, WA based Foundation Planning Group, Inc. helps investors find suitable viatical funding programs in which to place their money. "Generally, the programs have maturities of 1, 2, or 3 years with returns ranging from 12% to 42%," said the firm's president, Rod Schrader. "This is a great example of the private sector solving a social problem. It is a win-win for the terminally ill who are in need of money now and the investors who put the the money," he said.
"For individual investors, viaticals are an alternative to other savings plans such as CDs, bonds and annuities. What attracts both corporate and individual investors is the higher returns, the safety and the humanitarian aspect," said Schrader.
Foundation Planning Group, Inc. can be reached by phone at 800-737-1592.
CONTACT: Rod Schrader of Foundation Planning Group, Inc., 425-603-9100, or 800-737-1592, or fax, 425-603-9066/
Copyright (c) 1997/PR NewsWire. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Permissions Desk, PR Newswire, 810 Seventh Avenue, New York, NY 10019.
970806
PR970807
Copyright © 1997 - PRNewswire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through PRNewswire, Permissions, 810 Seventh Ave., 32nd Floor, New York, NY 10019 http://www.prnewswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .